Business
-
Alzheimer’s Drug Slows Cognitive Decline in Key Study
The pharmaceutical companies Biogen and Eisai said on Tuesday that a drug they are developing for Alzheimer’s disease had slowed…
-
Three Charts That Illustrate America’s Political and Economic Malaise
You're reading the On Politics newsletter, for Times subscribers only. A Times reader’s guide to the political news in Washington and…
-
Inflation Has Hit Tenants Hard. What About Their Landlords?
Of all the categories driving inflation in recent months, among the largest — and most persistent — is rent. In…
-
U.S. Suit Over Alliance of American Airlines and JetBlue Goes to Trial
A Justice Department effort to break up an alliance between American Airlines and JetBlue Airways is set to go to…
-
Meta Removes Chinese Effort to Influence U.S. Elections
Meta, the parent company of Facebook and Instagram, said on Tuesday that it had discovered and taken down what it…
-
The British Pound Is on Parity Watch
SIGN UP Want this in your inbox each morning? Get it sent to your inbox.The calm before the storm at the…
-
Dating Apps Thrive in China, but Not Just for Romance
When Qu Tongzhou, a photography assistant in Shanghai, set out on a long-awaited trip to western China in June, she…
-
Biogen Agrees to Pay $900 Million to Settle Lawsuit Over Kickbacks
The pharmaceutical company Biogen has agreed to pay $900 million to settle federal and state claims that it paid kickbacks…
-
Why a Weak British Pound Matters
The British pound on Monday briefly hit a record low against the dollar, extending losses after Britain’s new government on…
-
The Dollar Is Strong. That Is Good for the U.S. but Bad for the World.
The Federal Reserve’s determination to crush inflation at home by raising interest rates is inflicting profound pain in other countries…